Isabel Healthcare founder Jason Maude was recently featured on the "Be Seen, Be Heard" website in an interview by Doris Gilman at Health Thought Leadership One-to-One: Ideas you can adapt from inside and outside health and the life sciences.
In the interview, Mr. Maude discusses "A Diagnostic Tool for All Reasons." Gilman notes, "The Isabel tool complements a physician’s education and experience by helping him or her make more a fully-informed evaluation of a patient’s symptoms before starting treatment. Use of the Isabel tool saves valuable time and medical resources when the diagnosis is correct from the start."
Jason Maude serves as Chief Executive Officer and Co-founder of Isabel Healthcare Ltd. Prior to co-founding Isabel Healthcare Ltd, Maude spent 12 years working in the finance and investment banking industry in Europe. Throughout his career, Maude served as a top-ranked equity analyst at Kleinwort Benson Securities, Smith Barney and Dillon Read. While at Dillon Read, a prestigious U.S. investment bank, Maude served as partner and managing director of the company's UK office. This prominent position led Maude to AXA Investment Managers where he led equity research and managed $500 billion global investment initiatives.
In 1999, Maude's three-year-old daughter, Isabel fell seriously ill as a result of a misdiagnosis. Isabel's illness and experience inspired Maude to abandon his city career and create Isabel Healthcare.